Showing results (261-270 of 284) with videos related to
Sort By:
Pageof 29
Plos Pathogens|June 27, 2015
Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPsMarnie L Fusco, Takao Hashiguchi, Robyn Cassan, et al.Neurology|March 23, 2007
Phenotypic clustering of lamin A/C mutations in neuromuscular patientsS Benedetti, I Menditto, M Degano, et al.Neurology|September 8, 2010
Congenital muscular dystrophies with cognitive impairment. A population studyS Messina, C Bruno, I Moroni, et al.Neuromuscular Disorders : NMD|June 3, 2008
POMT1 and POMT2 mutations in CMD patients: a multicentric Italian studyS Messina, M Mora, E Pegoraro, et al.Neuromuscular Disorders : NMD|July 2, 2013
Six minute walk test in type III spinal muscular atrophy: a 12month longitudinal studyE Mazzone, F Bianco, M Main, et al.Nature Microbiology|May 9, 2018
Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER regionAndrew I Flyak, Natalia Kuzmina, Charles D Murin, et al.Neuromuscular Disorders : NMD|February 5, 2014
Hammersmith Functional Motor Scale and Motor Function Measure-20 in non ambulant SMA patientsE Mazzone, R De Sanctis, L Fanelli, et al.American Journal of Medical Genetics. Part A|December 14, 2007
Cerebroretinal microangiopathy with calcifications and cysts (CRMCC)T A Briggs, G M H Abdel-Salam, M Balicki, et al.Cell|January 26, 2016
Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus InfectionAndrew I Flyak, Xiaoli Shen, Charles D Murin, et al.Journal of Virology|October 16, 2015
Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan VirusesFrederick W Holtsberg, Sergey Shulenin, Hong Vu, et al.Pageof 29